Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical research trials and An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF clinical trial. Test subjects typically receive the most effective healthcare possible for their An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF



An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

For Condition: Lung Disease,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis
Status: No longer recruiting
Sponsor(s): InterMune ,
Synopsis: Open-label therapy will be administered to up to 220 patients, following completion of either InterMune Protocol GIPF-002 Part B or Protocol GIPF-004, to assess the long-term safety of subcutaneous Interferon gamma-1b. The study duration will be 5 years.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Enrollment in Protocol GIPF 002 Part B or GIPF-004 - Completion of the End of Treatment Visit in Protocol GIPF-002 Part B or the Study Completion Visit in GIPF-004 - Able to understand and sign a written informed consent form and comply with the requirements of the study
Total Enrollment: 220

Location and Contact Information:


Additional Information:
Study ID Numbers:  GIPF-006; 
Study Start Date: November 2003
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076635

Other Idiopathic Pulmonary Fibrosis Studies:
1. Ozone Exposure and Dose Delivered to Human Lungs

2. Study of the Disease Process of Lymphangioleiomyomatosis

3. Evaluation and Treatment of Patients with Lung Disease not Participating in Research

4. Segmental Bronchoalveolar Lavage

5. Natrecor in Pulmonary Hypertension

Related Studies:

Other Idiopathic Pulmonary Fibrosis Clinical Trials
Other Clinical Trials
Other Clinical Trials

An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF
Modify your Search

  Other Idiopathic Pulmonary Fibrosis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103